It also has a line of generic drugs (Angenerico) that includes about 60 molecules.
The company now has offices in 20 countries and distributes its products worldwide, employing around 5,000 people with a consolidated turnover of more than $1.6 billion.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze